Thrombolex, Inc.

New Filing
CIK: 0001703764·Other Health Care·DELAWARE·Filed: Mar 12, 2026
Total Offering

$51,105,000

Amount Sold

$32,775,000

Investors

22

First Sale

Feb 26, 2026

Offering Details

Type
Equity, Other: Includes Conversion of Outstanding Notes
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Michael J. Cerminaro
Related Person
Marvin Woodall
Related Person
John Cerminaro
Related Person
Paul A. Stewart
Related Person
David Bonita
Related Person
Sam Liang
Related Person
Keegan Harper
Related Person
Clay DeMarcus
Related Person

Company

Thrombolex, Inc.

4416 Route 27, Suite A

Kingston, NJ, 08528

844-792-6300

SEC Filing

0001703764-26-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Thrombolex, Inc. Form D Filing — $51,105,000 | FilingFlow